Latest Capital Strategy News

Thrive Tribe Technologies has repositioned WooBoard and REFFIND towards defence and workforce software, but its FY26 annual report flags a material uncertainty over the company’s ability to continue as a going concern. The pivot follows a $3.66 million loss, $2.57 million operating cash outflow and another $1 million placement after year-end.

Otto Energy plans to return approximately A$20 million to shareholders after consolidating its shares 100:1, with the proposed payment set at A$0.417 per post-consolidation share. The proposals require approval at the company’s 13 November 2026 AGM and remain subject to an outstanding ATO tax ruling.

EVT delivered growth across hotels, cinemas and Thredbo in FY2026 while outlining an approximately $500 million non-core property divestment programme. The group is also reviewing its structure as it redirects capital towards asset-light hotel expansion and considers potential special dividends.

Unith Ltd has closed its 1-for-7 entitlement offer, raising $295,725 from a partial take-up, leaving a significant shortfall that the company plans to place within three months.

Pengana Capital Group has lodged a formal application with the Takeovers Panel contesting the legitimacy and disclosure of Pengana International Equities’ recent capital management moves, including a contentious buy-back and rights issue.

Pengana Capital Group (ASX:PCG) has initiated an on-market buy-back program targeting nearly 10% of its issued ordinary shares, signaling a strategic move in capital management without requiring shareholder approval.

Resonance Health (ASX: RHT) reported a profitable turnaround in FY26, driven by growth across its imaging software, clinical trial services, and site network businesses.

Strata Investment Holdings delivered a £16.48 million comprehensive profit for H1 2026, driven by a strong revaluation of its investment portfolio and maiden royalty income from Botswana copper assets.

Scentre Group has sold half ownership of Westfield Mt Gravatt to Australian Retirement Trust for $882.5 million, marking a strategic joint venture and a 3.5% premium to book value.

Flagship Investments has initiated an on-market buyback program for up to $5 million of its FSIGA convertible notes, responding to noteholder demand for earlier repayment ahead of the October 2026 maturity.

Audalia Resources has raised $450,000 through a placement of 15 million shares at 3 cents each, aiming to push the Medcalf project towards production while maintaining working capital.

Adherium has tapped its major shareholder, Trudell Medical, for a further AUD 1 million unsecured loan to bolster working capital, adding to a recent USD 1.65 million facility.